[1]Malinchoc M, Kamath PS, Gordon FD, et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J].Hepatology, 2000, 31 (4) :864-871.
|
[2]Kamath PS, Wiesner RH, Malinchoc M, et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology, 2001, 33 (2) :464-470.
|
[3]孙丽华, 徐琴, 肖琳, 等.两种人工肝支持系统治疗重型肝炎143例[J].中国组织工程研究与临床康复, 2010, 14 (25) :4697-4700.
|
[4]Robert A, Chazouilleres O.Prothrombin time in liver failure:time, ratio, activity percentage, or international normalized ratio?[J].Hepatology, 1996, 24 (6) :l392-1394.
|
[5]Gotthardt D, Weiss KH, Baumg?rtner M, et al.Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation[J].BMC Gastroenterol, 2009, 9:72.
|
[6]Kamath PS, Kim WR.Is the change in MELD score a better indicator of mortality than baseline MELD score?[J].Liver Transplant, 2003, 9 (1) :19-21.
|
[7]Huo TI, Wu JC, Lin HC, et al.Evaluation of the increase in model for end-stage liver disease (Delta MELD) score over time as a prognostic predictor in patients with advanced cirrhosis:risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score[J].J Hepatol, 2005, 42 (6) :826-832.
|
[8]Gines P, Guevara M.Hyponatremia in cirrhosis:pathogenesis, clinical significance and management[J].Hepatology, 2008, 48 (3) :1002-1010.
|
[9]Biggins SW, Rodriguez HJ, Bacehetti P.Serum sodium predicts mortality in patients listed for liver transplantation[J].Hepatology, 2005, 41 (1) :32-39.
|
[10]Biggins SW, Kim WR, Terrauh NA, et al.Evidence-based incorporation of serum sodium concentration into MELD[J].Gastroenterology, 2006, 130 (6) :1652-1660.
|
[11]陈湖岸, 陈颖华, 赵辉, 等.改良终末期肝脏疾病模型对慢性乙型重型肝炎预后的评估[J].中华外科杂志, 2009, 47 (23) :1771-1774.
|
[12]Kim WR, Biggins SW, Kremers W, et al.Hyponatremia and mortality among patients on the liver-transplant waiting list[J].N Engl J Med, 2008, 359 (10) :1018-1026.
|
[13]Huo TI, Wang YW, Yang YY, et al.Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis[J].Liver Int, 2007, 27 (4) :498-506.
|
[14]Lv XH, Liu HB, Wang Y, et al.Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis[J].J Gastroenterol Hepatol, 2009, 24 (9) :1547-1553.
|
[15]Luca A, Angermayr B, Bertolini G, et al.An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis[J].Liver Transplant, 2007, 13 (8) :1174-1180.
|
[16]Huo TI, Lin HC, Huo SC, et al.Comparison of four model for end-stage liver disease based prognostic systems for cirrhosis[J].Liver Transplant, 2008, 14 (6) :837-844.
|
[17]Yun BC, Kim WR, Benson JT, et al.Impact of pretransplant hyponatremia on outcome following liver transplantation[J].Hepatology, 2009, 49 (5) :1610-1615.
|
[18]Habib A, Mihas AA, Abou-Assi SG, et al.High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics[J].Clin Gastroenterol Hepatol, 2005, 3 (3) :286-291.
|
[19]Jiang M, Liu F, Xiong W J, et al.Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis[J].World J Gastroenterol, 2010, 16 (11) :1397-1401.
|
[20]Ripoll C, Banares R, Rincon D, et al.Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era[J].Hepatology, 2005, 42 (4) :793-801.
|
[21]Wang YW, Huo TI, Yang YY, et al.Correlation and comparison of the model for end-stage liver disease, portal pressure and serum sodium for outcome prediction in patients with liver cirrhosis[J].J Clin Gastroenterol, 2007, 4l (7) :706-712.
|
[22]Liu F, Cai LY, Chen C, et al.Model for end-stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompenstated liver cirrhosis[J].J Dig Dis, 2010, 11 (6) :352-357.
|
[23]Kalabay L, Graf L, Voros K, et al.Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child Pugh and MELD scores[J].BMC Gastroenterol, 2007, 7:15.
|
[24]Somsouk M, Guy J, Biggins SW, et al.Ascites improves upon serum sodium and MELD for predicting mortality in patients with advanced liver disease[J].Aliment Pharmaeol Ther, 2009, 30 (7) :741-748.
|
[25]Sharma P, Shaubel DE, Sima CS, et al.Re-weighting the model for end-stage liver disease score components[J].Gastroenterology, 2008, 135 (5) :1575-1581.
|
[26]Kim WR, Asrani SK, Benson JT, et al.'Re-weighted'MELD and serum sodium as predictors of liver transplant waitlist mortality[J].Am J Transplant, 2009, 9:348.
|
[27]Biselli M, Gitto S, Gramenzi A, et al.Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant:which is the winner?[J].Liver Transplant, 2010, 16 (8) :964-973.
|
[28]Louvet A, Naveau S, Abdelnour M, et al.The Lille Model:a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids[J].Hepatology, 2007, 45 (6) :1348-1354.
|
[29]Gomez EV, Bertot LC, Oramas BG, et al.Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease[J].World J Gastroenterol, 2009, 15 (22) :2768-2777.
|
[30]Francoz C, Prie D, AbdelRazek W, et al.Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine:impact on the model for end-stage liver disease score[J].Liver Transplant, 2010, 16 (10) :1169-1177.
|
[31]Tripodi A, Chantarangkul V, Primignani M, et al.The international normalized ratio calibrated for cirrhosis (INR (liver) ) normalizes prothrombin time results for model for end-stage liver disease calculation[J].Hepatology, 2007, 46 (2) :520-527.
|